Answer:
The volume of solution B will increase
Explanation:
In a non-penetrating solute, there is denial of a solute to cross the cell membrane.This implies that the solute will not be able to cross the cell membrane. So if the biological membrane is serving as a partition between a solution A containing 400 mosmol/L non-penetrating solute and a solution B containing 600 mosmol/L non-penetrating solute, The volume of solution B will increase.
<span>microorganisms of different grous are not uniformly susceptible to chemical disinfection due to the level of resistance of the BACTERIA</span>
The correct answer is carcinoma. Mammary duct ectasia, papilloma and fibroadenoma are benign conditions of the breast. <span>Breast carcinoma is malign cancer that develops from breast tissue. Breast cancer is the<span> most common cancer among women</span> which can be the result of genetic or lifestyle factors. Invasive ductal carcinoma (IDC) is the most common type of breast cancer<span>.</span></span>
Answer:
Exoskeletons provide less mechanical leverage.
Explanation:
There are two types of skeleton in living beings: the endoskeleton (which vertebrates possess, is lined with epithelial tissue and has bones and cartilage) and the exoskeleton, a skeletal structure that is located outside the body of the living being. , is an external skeleton. They are common in invertebrate animals, which have no internal bone structure.
The exoskeleton is a tough but flexible outer layer, not formed by bones, unlike the vertebrate endoskeleton. Its function is mechanical, chemical and biological protection, avoid excessive water loss, muscle support and serves as a connecting point for legs, wings and other appendages. However, this type of skeleton provides less mechanical leverage.
On the other hand, the endoskeleton is the name given to the internal skeleton, which is inside the body. This body structure is mainly seen in vertebrate animals and has the function of supporting and moving the body, as well as protecting some internal organs. Unlike exoskeleton, the endoskeleton provides more mechanical leverage.
I believe the answer is <span>c. absorption
</span>The phase of pharmacokinetic that happens in the intestine is when the drug absorbed. A person with old age will have lower intestine motility. This will increase the transit time which will increase the amount of drug absorbed.
Age could also influence others pharmacokinetic parameter(<span>excretion, distribution, metabolism) but it is related with another organ, not intestine.</span>
